Biomaterial suture Vicryl Plus reduces wound-related complications

Por Zhang, Qian, Zhang, Chao, Fang, Xuanyu, Luo, Xu, Guo, Jiwei
Publicado no Ther Clin Risk Manag (2018)

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway

Por Jin, Dan, Wu, Yan, Shao, Cuijie, Gao, Yong, Wang, Deqiang, Guo, Jiwei
Publicado no Oncol Rep (2018)

Suppression of YAP by DDP disrupts colon tumor progression

Por Li, Kun, Guo, Jiwei, Wu, Yan, Jin, Dan, Jiang, Hong, Liu, Chengxia, Qin, Chengyong
Publicado no Oncol Rep (2018)

UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

Por Wu, Yan, Jin, Dan, Wang, Xiaohong, Du, Jing, Di, Weihua, An, Jiajia, Shao, Cuijie, Guo, Jiwei
Publicado no J Oncol (2019)

The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC

Por Jin, Dan, Guo, Jiwei, Wang, Deqiang, Wu, Yan, Wang, Xiaohong, Gao, Yong, Shao, Cuijie, Xu, Xin, Tan, Shuying
Publicado no EBioMedicine (2018)

Repression of YAP by NCTD disrupts NSCLC progression

Por Guo, Jiwei, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Li, XueLin, Xi, Sichuan
Publicado no Oncotarget (2016)

UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Home...

Por Jin, Dan, Guo, Jiwei, Wu, Yan, Du, Jing, Wang, Xiaohong, An, Jiajia, Hu, Baoguang, Kong, Lingqun, Di, Weihua, Wang, Wansheng
Publicado no Theranostics (2019)

Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression

Por Guo, Jiwei, Wu, Yan, Du, Jing, Yang, Lijuan, Chen, Weiwei, Gong, Kaikai, Dai, Juanjuan, Miao, Shuang, Jin, Dan, Xi, Sichuan
Publicado no Oncogenesis (2018)

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells

Por Guo, Jiwei, Jin, Dan, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Miao, Shuang, Xi, Sichuan
Publicado no EBioMedicine (2018)

Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment

Por Du, Jing, Chen, Weiwei, Yang, Lijuan, Dai, Juanjuan, Guo, Jiwei, Wu, Yan, Gong, Kaikai, Zhang, Jian, Yu, Ning, Xie, Zhen, Xi, Sichuan
Publicado no Sci Rep (2017)